We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+0.68%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.11B
AUM Growth
-$21.5M
Cap. Flow
-$27.3M
Cap. Flow %
-2.45%
Top 10 Hldgs %
49.74%
Holding
50
New
2
Increased
18
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
PII icon
Polaris
PII
+$25.4M
2
AAPL icon
Apple
AAPL
+$8.84M
3
BIIB icon
Biogen
BIIB
+$7.12M
4
EXPD icon
Expeditors International
EXPD
+$4.56M
5
RTX icon
RTX Corp
RTX
+$4.12M

Sector Composition

Rank Sector Weight
1 Technology 30.62%
2 Consumer Staples 20.08%
3 Healthcare 17.34%
4 Industrials 16.71%
5 Consumer Discretionary 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$897B
$64.6M 5.79%
2,653,011
+18,789
+0.7% +$435K
ORCL icon
2
Oracle
ORCL
$435B
$64.2M 5.76%
1,568,993
+29,623
+2% +$1.18M
MSFT icon
3
Microsoft
MSFT
$3.76T
$63.6M 5.71%
1,243,082
+2,556
+0.2% +$133K
AAPL icon
4
Apple
AAPL
$4.5T
$62.6M 5.62%
2,619,840
+355,848
+16% +$8.84M
RTX icon
5
RTX Corp
RTX
$302B
$57.1M 5.13%
885,222
+64,346
+8% +$4.12M
CSCO icon
6
Cisco
CSCO
$483B
$55.6M 4.99%
1,937,855
+39,556
+2% +$1.11M
CHRW icon
7
C.H. Robinson
CHRW
$17.3B
$50.1M 4.5%
675,335
+14,407
+2% +$1.05M
PG icon
8
Procter & Gamble
PG
$340B
$48.7M 4.37%
574,707
+2,461
+0.4% +$202K
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.13T
$44.9M 4.03%
310,371
+20,977
+7% +$3M
NVO
10
Novo Nordisk
NVO
$209B
$42.9M 3.85%
1,594,864
+87,112
+6% +$2.39M
BDX icon
11
Becton Dickinson
BDX
$48.9B
$42.8M 3.84%
258,977
-8,589
-3% -$1.37M
MDT icon
12
Medtronic
MDT
$114B
$40.8M 3.66%
470,666
-13,500
-3% -$1.09M
VAR
13
DELISTED
Varian Medical Systems, Inc.
VAR
$38.9M 3.49%
539,147
+16,780
+3% +$1.22M
KO icon
14
Coca-Cola
KO
$374B
$37.8M 3.4%
834,702
-14,876
-2% -$672K
JNJ icon
15
Johnson & Johnson
JNJ
$631B
$36.8M 3.3%
303,026
-2,733
-0.9% -$311K
PEP icon
16
PepsiCo
PEP
$188B
$36.1M 3.24%
340,634
-4,177
-1% -$431K
ACN icon
17
Accenture
ACN
$109B
$35.6M 3.19%
314,151
-9,496
-3% -$1.1M
MMM icon
18
3M
MMM
$93.9B
$35M 3.14%
239,277
-5,398
-2% -$761K
IBM icon
19
IBM
IBM
$223B
$32.7M 2.94%
225,685
+7,292
+3% +$1.04M
SYY icon
20
Sysco
SYY
$40.1B
$30.3M 2.72%
598,063
-233,756
-28% -$11.3M
BIIB icon
21
Biogen
BIIB
$30.6B
$28.9M 2.59%
119,335
+27,026
+29% +$7.12M
PII icon
22
Polaris
PII
$3.97B
$26.3M 2.36%
321,495
+286,598
+821% +$25.4M
CTSH icon
23
Cognizant
CTSH
$26.3B
$26.1M 2.34%
455,167
+44,205
+11% +$2.67M
NKE icon
24
Nike
NKE
$62.5B
$24.3M 2.18%
439,370
-5,868
-1% -$334K
EXPD icon
25
Expeditors International
EXPD
$23.3B
$24M 2.15%
489,605
+94,020
+24% +$4.56M

Similar funds

Saratoga Research & Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Saratoga Research & Investment Management held 50 positions worth $1.11B, down 1.9% from $1.14B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Saratoga Research & Investment Management's Q2 2016 filing shows 2 new, 18 increased, 13 reduced and 4 closed positions. Its largest new stake was Starbucks: 8,274 shares worth $473K. The largest sale was BAXALTA INC COM STK (DE), an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Saratoga Research & Investment Management's largest Q2 2016 buy was Starbucks: 8,274 shares worth $473K.
  • Saratoga Research & Investment Management added most to Polaris in Q2 2016, an estimated $25.4M increase.
  • Saratoga Research & Investment Management's biggest Q2 2016 reduction was Omnicom Group, cutting an estimated $17.6M.
  • Saratoga Research & Investment Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $17.9M.
  • Saratoga Research & Investment Management's ten largest holdings make up 50% of its $1.11B portfolio in Q2 2016.
  • Saratoga Research & Investment Management opened 2 new positions and closed 4 in Q2 2016.
  • Saratoga Research & Investment Management's portfolio value fell 1.9% quarter-over-quarter to $1.11B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2016, filed 29 Jul 2016.